InvestSMART

Neurotech International Limited (ASX: NTI) - Announcements

Current share price for NTI : $0.015 0.001 (3.57%)+

ASX company news and announcements for Neurotech International Limited (NTI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neurotech International Limited (NTI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neurotech International Limited (NTI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neurotech International Limited (NTI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Proposed issue of Securities - NTI 2 Nov 2020 9:58AM $0.026 $0.015 fallen by 44.23%
$23 Interim Results and Capital Raising 2 Nov 2020 9:58AM $0.026 $0.015 fallen by 44.23%
$23 Quarterly Report and Appendix 4C 2 Nov 2020 9:14AM $0.026 $0.015 fallen by 44.23%
$23 Proposed issue of Securities - NTI 29 Oct 2020 1:14PM $0.026 $0.015 fallen by 44.23%
$23 Notice of Annual General Meeting/Proxy Form 29 Oct 2020 12:15PM $0.026 $0.015 fallen by 44.23%
$23 Trading Halt 29 Oct 2020 9:15AM $0.026 $0.015 fallen by 44.23%
$23 Response to ASX Price and Volume Query 22 Oct 2020 5:42PM $0.026 $0.015 fallen by 44.23%
$23 Initial and Final Director's Interest Notices 19 Oct 2020 9:17AM $0.021 $0.015 fallen by 30.95%
$23 Proposed issue of Securities - NTI 19 Oct 2020 9:16AM $0.021 $0.015 fallen by 30.95%
$23 New Chairman Appointed 19 Oct 2020 9:14AM $0.021 $0.015 fallen by 30.95%
$23 Change of Director's Interest Notice x 4 6 Oct 2020 5:32PM $0.014 $0.015 risen by 3.57%
$23 Becoming a substantial holder 2 Oct 2020 3:39PM $0.013 $0.015 risen by 11.54%
$23 Completion of Acquisition 30 Sep 2020 9:47AM $0.013 $0.015 risen by 11.54%
$23 NTI Commences Landmark In Vitro Trials of Cannabis Strains 23 Sep 2020 8:20AM $0.014 $0.015 risen by 3.57%
$23 Ceasing to be a substantial holder 10 Sep 2020 8:16AM $0.013 $0.015 risen by 11.54%
$23 Completion of Placement 7 Sep 2020 6:22PM $0.014 $0.015 risen by 3.57%
$23 Neurotech Proceeds to in vitro trials after Positive Results 7 Sep 2020 9:06AM $0.014 $0.015 risen by 3.57%
$23 Neurotech secures Brain Therapeutics as Greece distributor 3 Sep 2020 9:17AM $0.015 $0.015 fallen by 3.33%
$23 Appendix 2A 2 Sep 2020 5:54PM $0.015 $0.015 fallen by 3.33%
$23 Appendix 4E and Annual Report Updated 31 Aug 2020 4:48PM $0.015 $0.015 fallen by 3.33%
$23 Appendix 4G 31 Aug 2020 4:25PM $0.015 $0.015 fallen by 3.33%
$23 Appendix 4E and Annual Report 31 Aug 2020 4:24PM $0.015 $0.015 fallen by 3.33%
$23 Results of Meeting 31 Aug 2020 3:01PM $0.015 $0.015 fallen by 3.33%
$23 Disclosure Document 26 Aug 2020 12:56PM $0.013 $0.015 risen by 11.54%
$23 Response to ASX price query 21 Aug 2020 10:45AM $0.016 $0.015 fallen by 9.38%

451 - 475 of 694 results

Page 19 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.